Will the FDA Ban Peptides? A Calm Look at What Is Actually Happening

What Is Happening

The FDA reviews substances compounding pharmacies may use. Some peptides have been restricted; others reviewed and kept; the list moves.

At Lower Risk

Semaglutide and tirzepatide (approved drugs), sermorelin and tesamorelin (approved-drug histories), thymosin alpha-1, PT-141 (approved brand), NAD+, glutathione.

Under Review at Times

Several recovery and growth-hormone peptides. We prescribe only what is permitted and switch patients when something changes.

What It Means for You

Prescribed, tested medication from a provider who tracks the list is the safe position. Research vials are the risky one.

Common Questions

All treatments are medical services. Every guest is screened, and every treatment is provided only under the clearance, prescription or standing protocol of a licensed medical provider. Nothing on this page is a diagnosis or a promise of results. For an emergency, call 911.